Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients

Lung Cancer

Volumn 61, Issue 2, 2008, Pages 170-176

  Brunsvig, Paal Fr ^a   Flatmark, Kjersti ^a,b   Aamdal, Steinar ^a   Høifødt, Hanne ^b   Le, Hang ^b   Jakobsen, Erling ^a   Sandstad, Berit ^a   Fodstad, Øystein ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Bone marrow; Clinical study; Disseminated tumor cells; Ep Cam; Lung cancer; Micrometastasis; MOC31

Indexed keywords

ANTIBODY;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW METASTASIS; CANCER CELL; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CELL ISOLATION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; PRIORITY JOURNAL; REPEAT PROCEDURE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BONE MARROW; BONE MARROW NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION MOLECULES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 47649129262     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.12.018     Document Type: Article

References (32)

1. Landis S.H., Murray T., Bolden S., and Wingo P.A. Cancer statistics. CA Cancer J Clin 48 1 (1998) 6-29
2. Mountain C.F. Revisions in the International system for staging lung cancer. Chest 111 6 (1997) 1710-1717
3. Vlems F.A., Ruers T.J., Punt C.J., Wobbes T., and van Muijen G.N. Relevance of disseminated tumour cells in blood and bone marrow of patients with solid epithelial tumours in perspective. Eur J Surg Oncol 29 4 (2003) 289-302
4. Poncelet A.J., Weynand B., Ferdin F., Robert A.R., and Noirhomme P.H. Bone marrow micrometastasis might not be a short-term predictor of survival in early stages non-small cell lung carcinoma. Eur J Cardiothorac Surg 20 3 (2001) 481-488
5. Cote R.J., Beattie E.J., Chaiwun B., Shi S.R., Harvey J., Chen S.C., et al. Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann Surg 222 4 (1995) 415-423
6. Ohgami A., Mitsudomi T., Sugio K., Tsuda T., Oyama T., Nishida K., et al. Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer. Ann Thorac Surg 64 2 (1997) 363-367
7. Passlick B., Kubuschok B., Izbicki J.R., Thetter O., and Pantel K. Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer. Ann Thorac Surg 68 6 (1999) 2053-2058
8. Hsu C.P., Shen G.H., and Ko J.L. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer. Lung Cancer 52 3 (2006) 349-357
9. Mattioli S., D'Ovidio F., Tazzari P., Pilotti V., Daddi N., Bandini G., et al. Iliac crest biopsy versus rib segment resection for the detection of bone marrow isolated tumor cells from lung and esophageal cancer. Eur J Cardiothorac Surg 19 5 (2001) 576-579
10. Socinski M.A., Morris D.E., Masters G.A., and Lilenbaum R. Chemotherapeutic management of stage IV non-small cell lung cancer. Chest 123 1 Suppl. (2003) 226S-243S
11. Hansen H.H. An update on management of lung cancer-Acta Oncologica Lecture-Vasteras 21 March 2002. Acta Oncol 41 6 (2002) 500-506
12. Van Meerbeeck J.P. Staging of non-small cell lung cancer: consensus, controversies and challenges. Lung Cancer 34 Suppl. 2 (2001) S95-S107
13. Beiske K., Myklebust A.T., Aamdal S., Langholm R., Jakobsen E., and Fodstad O. Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods. Am J Pathol 141 3 (1992) 531-538
14. Flatmark K., Bjornland K., Johannessen H.O., Hegstad E., Rosales R., Harklau L., et al. Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients. Clin Cancer Res 8 2 (2002) 444-449
15. Faye R.S., Aamdal S., Hoifodt H.K., Jacobsen E., Holstad L., Skovlund E., et al. Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients. Clin Cancer Res 10 12 Pt 1 (2004) 4134-4139
16. Bruland O.S., Hoifodt H., Saeter G., Smeland S., and Fodstad O. Hematogenous micrometastases in osteosarcoma patients. Clin Cancer Res 11 13 (2005) 4666-4673
17. Wiedswang G., Borgen E., Karesen R., and Naume B. Detection of isolated tumor cells in BM from breast-cancer patients: significance of anterior and posterior iliac crest aspirations and the number of mononuclear cells analyzed. Cytotherapy 5 1 (2003) 40-45
18. Pantel K., Izbicki J., Passlick B., Angstwurm M., Haussinger K., Thetter O., et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 347 9002 (1996) 649-653
19. Yasumoto K., Osaki T., Watanabe Y., Kato H., and Yoshimura T. Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: a multicenter prospective study. Ann Thorac Surg 76 1 (2003) 194-201
20. Jiao X., and Krasna M.J. Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology. Ann Thorac Surg 74 1 (2002) 278-284
21. Coello M.C., Luketich J.D., Litle V.R., and Godfrey T.E. Prognostic significance of micrometastasis in non-small-cell lung cancer. Clin Lung Cancer 5 4 (2004) 214-225
22. Wieder R. Insurgent micrometastases: sleeper cells and harboring the enemy. J Surg Oncol 89 4 (2005) 207-210
23. Epstein R.J. Maintenance therapy to suppress micrometastasis: the new challenge for adjuvant cancer treatment. Clin Cancer Res 11 15 (2005) 5337-5341
24. Braun S., Kentenich C., Janni W., Hepp F., de W.J., Willgeroth F., et al. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol 18 1 (2000) 80-86
25. Al-Hajj M., Becker M.W., Wicha M., Weissman I., and Clarke M.F. Therapeutic implications of cancer stem cells. Curr Opin Genet Dev 14 1 (2004) 43-47
26. 'Brien C.A., Pollett A., Gallinger S., and Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 7123 (2007) 106-110
27. Passlick B., Sienel W., Seen-Hibler R., Wockel W., Thetter O., and Pantel K. The 17-1A antigen is expressed on primary, metastatic and disseminated non-small cell lung carcinoma cells. Int J Cancer 87 4 (2000) 548-552
28. Went P., Vasei M., Bubendorf L., Terracciano L., Tornillo L., Riede U., et al. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer 94 1 (2006) 128-135
29. Marth C., Kisic J., Kaern J., Trope C., and Fodstad O. Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis. Cancer 94 3 (2002) 707-712
30. Balzar M., Winter M.J., de Boer C.J., and Litvinov S.V. The biology of the 17-1A antigen (Ep-CAM). J Mol Med 77 10 (1999) 699-712
31. Myklebust A.T., Beiske K., Pharo A., Davies C.D., Aamdal S., and Fodstad O. Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis. Br J Cancer Suppl 14 (1991) 49-53
32. Tveito S., Maelandsmo G.M., Hoifodt H.K., Rasmussen H., and Fodstad O. Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value. Clin Exp Metastasis (2007)